Pulsar 35
Self-Expanding Stent System
Indicated for use in patients with atherosclerotic disease of the femoral and proximal popliteal arteries, in particular for the treatment of insufficient results after percutaneous transluminal angioplasty (PTA).
Pulsar 35
Self-Expanding Stent System
Indicated for use in patients with atherosclerotic disease of the femoral and proximal popliteal arteries, in particular for the treatment of insufficient results after percutaneous transluminal angioplasty (PTA).
140 μm thin struts
Clinically proven
Tri-axial delivery system
140 μm thin struts
Clinically proven
Tri-axial delivery system
Technical data
Delivery System | |
---|---|
Catheter type | OTW |
Recommended guide catheter | 0.035″ |
Stent material | Nitinol |
Strut thickness | 140 μm |
Strut width | 85 μm |
Stent coating | proBIO® (Amorphous Silicon Carbide) |
Stent markers | 6 gold markers each end |
Sizes | ø 5.0 – 7.0 mm: L: 30 – 200 mm |
Shaft | 6F, hydrophobic coating, tri-axial |
Usable length | 90 cm and 135 cm |
Technical data
Delivery System | |
---|---|
Catheter type | OTW |
Recommended guide catheter | 0.035″ |
Stent material | Nitinol |
Strut thickness | 140 μm |
Strut width | 85 μm |
Stent coating | proBIO® (Amorphous Silicon Carbide) |
Stent markers | 6 gold markers each end |
Sizes | ø 5.0 – 7.0 mm: L: 30 – 200 mm |
Shaft | 6F, hydrophobic coating, tri-axial |
Usable length | 90 cm and 135 cm |